🇺🇸 FDA

Intelligence · Clinical Pipeline

Infectious disease R&D Pipeline

Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Programs
1,126

Quick answer

Infectious disease: NovaPharmaNews indexes 1,126 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.

Top sponsors

Page 14 of 24

  1. Ursodeoxycholic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 small molecule completed

    1 trial

  2. VBR

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 small molecule terminated

    1 trial

  3. VCH-222 or matching placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 2 small molecule completed

    1 trial

  4. VCH-759 (BCH-27759)

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C, Chronic

    phase 2 small molecule completed

    1 trial

  5. VIR-2218

    Vir Biotechnology

    Hepatitis D, Chronic

    phase 2 small molecule active

    1 trial

  6. VIR-2218

    Alnylam Netherlands B.V.

    Hepatitis B, Chronic

    phase 2 small molecule completed

    1 trial

  7. VIR-2218

    Alnylam Netherlands B.V.

    Chronic Hepatitis B

    phase 2 small molecule completed

    2 trials

  8. VIR-2218

    Vir Biotechnology

    Hepatitis B, Chronic

    phase 2 small molecule completed

    1 trial

  9. VIR-2218

    Vir Biotechnology

    Chronic Hepatitis B

    phase 2 small molecule completed

    1 trial

  10. VIR-3434

    Vir Biotechnology

    Hepatitis B, Chronic

    phase 2 small molecule completed

    1 trial

  11. VIR-3434, VIR-2218

    Vir Biotechnology

    Chronic Hepatitis D Virus (HDV) Infection

    phase 2 small molecule active

    1 trial

  12. VK2809

    Viking Therapeutics

    NASH - Nonalcoholic Steatohepatitis

    phase 2 small molecule completed

    1 trial

  13. VLA2001

    United Therapeutics Europe Ltd

    SARS-CoV-2 Virus Infection

    phase 2 mab completed

    1 trial

  14. VMP001

    United Therapeutics Europe Ltd

    Malaria

    phase 2 mab completed

    1 trial

  15. VOX

    Gilead Sciences Ireland UC

    Hepatitis C Virus Infection

    phase 2 small molecule completed

    1 trial

  16. VP20621

    Takeda

    Clostridium Difficile Infection

    phase 2 mab completed

    1 trial

  17. VRC-HIVDNA016-00-VP

    United Therapeutics Europe Ltd

    HIV Infections

    phase 2 mab completed

    1 trial

  18. VX-135

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 2 small molecule completed

    3 trials

  19. VX-222

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C Virus

    phase 2 small molecule completed

    2 trials

  20. VX-950

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    phase 2 small molecule completed

    2 trials

  21. Vaborem 1 g/1 g powder for concentrate for solution for infusion

    A.Menarini Australia Pty Limited

    Suspected or confirmed Gram negative infections

    phase 2 small molecule active

    1 trial

  22. Vaccine PvCS N+C+R

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria

    phase 2 mab completed

    1 trial

  23. Vaccine PvCS N+C+R 150 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria, Vivax

    phase 2 mab active

    1 trial

  24. Vancomycin

    Cardiff Oncology

    Late Onset Neonatal Sepsis

    phase 2 small molecule terminated

    1 trial

  25. Veklury 100 mg powder for concentrate for solution for infusion

    MEDA Pharma GmbH & Co. KG

    COVID-10 infection

    phase 2 small molecule active

    1 trial

  26. Vir-3434, Vir-2218, Pegasys 180 micrograms solution for injection in pre-filled syringe

    Vir Biotechnology

    Chronic Hepatitis B Virus Infection

    phase 2 small molecule active

    1 trial

  27. Visual match to product

    ViiV Healthcare Pty Ltd

    HIV Infections

    phase 2 small molecule active

    1 trial

  28. Voclosporin

    Aurinia Pharmaceuticals

    Covid19

    phase 2 small molecule completed

    1 trial

  29. Vortioxetine

    COGNITION THERAPEUTICS INC

    Post-COVID-19 Condition

    phase 2 small molecule completed

    1 trial

  30. Workshop

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 other completed

    1 trial

  31. accelerated intermittent theta burst stimulation

    United Therapeutics Europe Ltd

    Long COVID

    phase 2 other active

    1 trial

  32. alb-interferon alfa 2b

    Novartis Pharmaceuticals

    Chronic Hepatitis C

    phase 2 small molecule completed

    1 trial

  33. casirivimab+imdevimab

    Regeneron UK Limited

    COVID-19

    phase 2 small molecule terminated

    2 trials

  34. coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 small molecule completed

    1 trial

  35. dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 2 small molecule completed

    1 trial

  36. efinopegdutide, efinopegdutide, efinopegdutide, Placebo to MK-6024, efinopegdutide

    Merck Sharp and Dohme

    Metabolic Dysfunction-Associated Steatohepatitis

    phase 2 small molecule active

    1 trial

  37. empowerment theory-based small group discussion

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    phase 2 other completed

    1 trial

  38. lanadelumab

    Takeda

    COVID-19

    phase 2 mab completed

    1 trial

  39. low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 mab completed

    1 trial

  40. meningococcal ACWY (vaccine)

    GlaxoSmithKline

    Infections, Meningococcal

    phase 2 mab completed

    1 trial

  41. middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Norovirus Infections

    phase 2 mab active

    1 trial

  42. oritavancin

    Targanta Netherlands B.V.

    Staphylococcal Skin Infections

    phase 2 small molecule completed

    1 trial

  43. placebo

    The First People's Hospital of Lianyungang

    COVID-19 Thalidomide

    phase 2 small molecule active

    1 trial

  44. pneumococcal polysaccharide and protein conjugate vaccines

    United Therapeutics Europe Ltd

    Pneumococcal Infections

    phase 2 mab completed

    1 trial

  45. ribavirin (RBV)

    Boehringer Ingelheim

    Hepatitis C

    phase 2 small molecule completed

    1 trial

  46. standard of care (SOC) Nucleoside reverse transcriptase inhibitor (NrtI)

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 small molecule terminated

    1 trial

  47. standard triple region

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Helicobacter Pylori Infection

    phase 2 small molecule completed

    1 trial

  48. sterile saline solution (0.9% w/v solution of NaCl in water).

    GlaxoSmithKline

    Urinary Tract Infections

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many infectious disease pipeline programs are tracked?

1,126 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.